Fertilisers & Chemical Travancore
Fertilisers & Chemical Travancore
ChemicalsKey Fundamentals
MidcapFertilizersChemicalsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
5- Stock is trading at 37.4 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 11.9% over past five years.
- Company has a low return on equity of 8.76% over last 3 years.
- Earnings include an other income of Rs.159 Cr.
Growth Rate
AI Analysis — Bull vs Bear
Fertilizers & Chemicals Travancore Ltd (FACT) is a government-sector chemicals company with a market cap of ₹50,436 Cr that has seen a sharp reversal in profitability, with TTM profit declining 231% and last-year ROE turning negative at -3%. While the stock has delivered a strong 5-year CAGR of 44% and 10-year CAGR of 43%, the current negative PE of -482.7 and a P/B of 37.94 signal significant valuation and earnings concerns.
- Strong long-term stock price appreciation with a 10-year CAGR of 43% and 5-year CAGR of 44%, indicating sustained investor interest over extended periods
- TTM sales growth of 32% suggests a meaningful recent revenue recovery after a 3-year compounded sales decline of -3%
- 5-year compounded sales growth of 12% and 10-year compounded sales growth of 13% show the company has maintained a reasonable topline trajectory over longer horizons
- 5-year average ROE of 27% demonstrates that the company has historically been capable of generating strong shareholder returns during favorable cycles
- 10-year compounded profit growth of 7% indicates the company has delivered positive earnings growth over a full business cycle despite recent weakness
- Company is expected to deliver a good upcoming quarter, which could mark a potential inflection point after the recent earnings downturn
- Market cap of ₹50,436 Cr reflects significant scale and institutional presence as a public-sector fertilizer and chemicals entity
- Negative trailing PE of -482.7 indicates the company is currently loss-making, with TTM profits declining by 231% year-over-year
- Stock trades at an extremely elevated P/B ratio of 37.94 times book value, far above typical chemical sector valuations
- Last-year ROE has turned negative at -3%, a sharp deterioration from the 3-year average of 9% and 5-year average of 27%
- Earnings quality is a concern as other income of ₹159 Cr forms a significant portion of reported results, masking weaker core operating performance
- Low interest coverage ratio signals potential stress in servicing debt obligations from operating earnings
- 5-year sales growth of only 11.9% is modest for a chemicals company, and 3-year compounded sales have actually declined at -3%
- 3-year ROE of just 8.76% is low for a company trading at nearly 38x book value, suggesting the valuation is disconnected from fundamental returns
- Stock price has already declined 20% over the past 1 year, reflecting deteriorating fundamentals and potential further downside risk if earnings do not recover
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- ₹438 crore penal interest demand Sep 02
Government imposed ₹438.20 crore penal interest on outstanding GoI loan — ₹389.51 crore for Apr 2018 to Mar 2026 and ₹48.69 crore for FY2026-27. FACT is seeking a waiver but outcome remains uncertain.
- Q1 swings to net loss Sep 02
FACT reported a consolidated net loss of ₹61.94 crore in Q1 FY27 versus a net profit of ₹4.28 crore a year ago, despite 20.2% YoY revenue growth to ₹1,253.4 crore.
- EBITDA turns negative Sep 02
EBITDA swung to a loss of ₹29.8 crore from a profit of ₹23.98 crore YoY, a ₹54 crore deterioration, showing higher revenue failed to convert into operating profit.
- Stock under pressure Sep 02
Shares closed at ₹807.00, down 0.88% (₹7.20), reflecting investor concern over deteriorating financials and the penal interest overhang.
- Revenue up 20% YoY Sep 02
Revenue from operations grew 20.2% YoY to ₹1,253.4 crore from ₹1,042.8 crore, generating roughly ₹211 crore in additional topline.
- Two independent directors appointed Sep 02
Ministry notified appointment of Narpat Singh Rathore and Ramawater Rajgarhia as non-official independent directors on Aug 13 for a three-year term.
- Contingent liability disclosure widened Sep 02
FACT had previously disclosed penal interest only from Apr 2022 as contingent liability; the new communication extends the period back to Apr 2018, broadening the reported exposure.
TL;DR: FACT is under significant financial stress. While topline grew 20% YoY, operating performance collapsed with EBITDA swinging to a loss, and a ₹438 crore penal interest demand from the government adds a material balance-sheet risk. The sole bright spot is strong revenue growth, but cost discipline is clearly lacking. The near-term outlook hinges on whether the ministry grants a penal interest waiver and whether the company can restore operating profitability in coming quarters.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,233 | 1,663 | 1,097 | 1,058 | 600 | 1,449 | 949 | 1,053 | 1,043 | 1,629 | 1,568 | 1,484 | 1,253 |
| Expenses | 1,086 | 1,531 | 1,054 | 1,023 | 656 | 1,414 | 918 | 968 | 1,019 | 1,590 | 1,611 | 1,435 | 1,283 |
| Operating Profit | 147 | 132 | 43 | 36 | -57 | 35 | 32 | 85 | 24 | 39 | -43 | 49 | -30 |
| OPM % | 12% | 8% | 3.9% | 3.4% | -9% | 2.4% | 3.3% | 8% | 2.3% | 2.4% | -2.7% | 3.3% | -2.4% |
| Other Income | -7 | 39 | 54 | -129 | 60 | 48 | 57 | 76 | 52 | 51 | 39 | 34 | 34 |
| Interest | 63 | 61 | 62 | 61 | 62 | 61 | 62 | 60 | 62 | 62 | 62 | 64 | 62 |
| Depreciation | 5 | 5 | 5 | 11 | 5 | 6 | 12 | 13 | 7 | 8 | 9 | 12 | 7 |
| PBT | 72 | 105 | 30 | -166 | -64 | 15 | 15 | 88 | 7 | 21 | -74 | 6 | -64 |
| Tax % | 0% | 0% | 0% | -52% | -24% | 28% | 46% | 20% | 40% | 2% | -8% | 46% | -4% |
| Net Profit | 72 | 105 | 30 | -79 | -49 | 11 | 8 | 71 | 4 | 21 | -68 | 3 | -62 |
| EPS in Rs | 1.11 | 1.63 | 0.47 | -1.22 | -0.75 | 0.17 | 0.12 | 1.09 | 0.07 | 0.32 | -1.05 | 0.05 | -0.96 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,979 | 1,736 | 1,867 | 1,927 | 1,955 | 2,770 | 3,259 | 4,425 | 6,198 | 5,051 | 4,051 | 5,724 | 5,934 |
| Expenses | 2,157 | 1,959 | 1,821 | 1,759 | 1,945 | 2,491 | 2,708 | 3,829 | 5,443 | 4,693 | 3,956 | 5,655 | 5,919 |
| Operating Profit | -178 | -223 | 45 | 168 | 10 | 279 | 551 | 596 | 755 | 358 | 95 | 69 | 15 |
| OPM % | -9% | -13% | 2.4% | 9% | 0.5% | 10% | 17% | 13% | 12% | 7% | 2.3% | 1.2% | 0.3% |
| Other Income | -6 | 41 | 18 | 42 | 457 | 1,004 | 68 | 22 | 136 | -42 | 241 | 176 | 159 |
| Interest | 196 | 252 | 305 | 321 | 281 | 289 | 245 | 244 | 248 | 247 | 246 | 250 | 250 |
| Depreciation | 20 | 18 | 21 | 17 | 23 | 18 | 23 | 27 | 30 | 27 | 37 | 36 | 35 |
| PBT | -400 | -452 | -263 | -129 | 163 | 976 | 350 | 346 | 613 | 42 | 54 | -40 | -111 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -206% | 23% | -1% | — |
| Net Profit | -400 | -452 | -263 | -129 | 163 | 976 | 350 | 346 | 613 | 128 | 41 | -40 | -106 |
| EPS in Rs | -6.18 | -6.99 | -4.06 | -1.99 | 2.51 | 15.08 | 5.42 | 5.35 | 9.47 | 1.98 | 0.64 | -0.61 | -1.64 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 11% | 49% | 61% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 647 | 647 | 647 | 647 | 647 | 647 | 647 | 647 | 647 | 647 | 647 | 647 |
| Reserves | -1,504 | -1,956 | -2,159 | -2,286 | -2,119 | -1,139 | -827 | 15 | 627 | 711 | 724 | 703 |
| Borrowings | 1,074 | 1,811 | 2,402 | 2,278 | 2,274 | 1,821 | 1,822 | 1,838 | 1,842 | 1,810 | 1,805 | 3,985 |
| Other Liabilities | 1,449 | 1,167 | 715 | 1,215 | 1,547 | 1,317 | 1,756 | 2,276 | 2,379 | 2,682 | 2,860 | 631 |
| Total Liabilities | 1,667 | 1,668 | 1,605 | 1,854 | 2,348 | 2,646 | 3,399 | 4,775 | 5,494 | 5,850 | 6,036 | 5,967 |
| Fixed Assets | 282 | 270 | 297 | 295 | 296 | 258 | 286 | 816 | 814 | 827 | 951 | 949 |
| CWIP | 25 | 22 | 25 | 18 | 18 | 39 | 55 | 43 | 105 | 224 | 216 | 294 |
| Investments | 4 | 4 | 46 | 59 | 69 | 78 | 86 | 98 | 113 | 130 | 158 | 185 |
| Other Assets | 1,357 | 1,373 | 1,238 | 1,482 | 1,966 | 2,271 | 2,972 | 3,819 | 4,463 | 4,669 | 4,710 | 4,539 |
| Total Assets | 1,667 | 1,668 | 1,605 | 1,854 | 2,348 | 2,646 | 3,399 | 4,775 | 5,494 | 5,850 | 6,036 | 5,967 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 192 | -206 | 31 | 224 | -410 | 214 | 1,021 | 152 | 638 | 280 | 140 | -996 |
| Investing | -9 | -3 | 75 | -3 | 416 | 336 | -854 | -157 | -765 | 213 | -282 | 952 |
| Financing | -180 | 224 | -94 | -207 | -45 | -508 | -36 | 8 | -5 | -107 | -75 | -6 |
| Net Cash Flow | 3 | 15 | 12 | 14 | -40 | 42 | 130 | 3 | -132 | 386 | -217 | -49 |
| Free Cash Flow | 183 | -209 | 24 | 215 | 0 | 1,144 | 988 | 88 | 556 | 126 | -13 | -1,106 |
| CFO/OP | -108 | 92 | 69 | 133 | -4,256 | 81 | 184 | 24 | 84 | 78 | 147 | -1,439 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 2 | 1 | 99 | 69 | 76 | 51 | 12 | 14 | 28 | 11 | 26 | 22 |
| Inventory Days | 146 | 123 | 158 | 184 | 197 | 138 | 112 | 93 | 103 | 134 | 128 | 101 |
| Days Payable | 180 | 166 | 109 | 150 | 120 | 49 | 76 | 77 | 37 | 54 | 60 | 20 |
| Cash Conversion Cycle | -32 | -41 | 148 | 102 | 152 | 141 | 47 | 30 | 94 | 91 | 94 | 104 |
| Working Capital Days | -157 | 26 | -1 | -20 | 13 | -60 | -228 | -159 | -120 | -175 | -239 | -126 |
| ROCE % | -41% | -61% | 6% | 25% | 1% | 27% | 40% | 33% | 30% | 17% | 9% | 5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Fertilisers & Chemical Travancore insights
60 extracted metrics + investor summaries across FY06–FY26.
Documents
Frequently Asked Questions about Fertilisers & Chemical Travancore
What does Fertilizers & Chemicals Travancore Ltd do?
Where is Fertilizers & Chemicals Travancore Ltd (FACT) listed?
Which sector does Fertilizers & Chemicals Travancore Ltd belong to?
What is the market capitalisation of Fertilizers & Chemicals Travancore Ltd?
What is the PE ratio of Fertilizers & Chemicals Travancore Ltd?
What is the 52-week high and low of Fertilizers & Chemicals Travancore Ltd?
Does Fertilizers & Chemicals Travancore Ltd pay dividends?
What is the Return on Equity (ROE) of Fertilizers & Chemicals Travancore Ltd?
Company Information
Fertilizers & Chemicals Travancore Ltd (FACT), incorporated in the year 1943, is the first large-scale fertiliser plant in India at Udyogamandal, Kochi, Kerala. The company is engaged in the manufacturing and selling of fertilizers, its by-products and Caprolactam. It is under the administrative control of the Department of Fertilizers, Ministry of Chemicals & Fertilizers, Government of India.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/FACT.md for Fertilizers & Chemicals Travancore Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.